Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Transplantation Proceedings

• Publication date

  1987-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 2445076PMCID PMC2903874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

  1987cited by this paper
• Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.

  1987cited by this paper
• THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS.

  1987cited by this paper
• STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG‐TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATS

  1987cited by this paper
• Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

  1987cited by this paper
• IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION.

  1987cited by this paper

• Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs

  2024cites this paper
• THIRTY YEARS OF TACROLIMUS IN CLINICAL PRACTICE.

  2020cites this paper
• Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations

  2017cites this paper
• Forty years of publication of transplantation proceedings--the second decade: the cyclosporine revolution.

  2009cites this paper
• An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: A comparison of dual vs. triple drug therapy

  2005cites this paper
• Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant1.

  2002cites this paper
• Evaluation of the clinical and histologic features of renal allograft rejection in cats.

  2002cites this paper
• Effect of the immunosuppressants FK506 and D-allose on allogenic orthotopic liver transplantation in rats.

  2000cites this paper
• Osteomyocutaneous flap as a preclinical composite tissue allograft: Swine model

  2000cites this paper
• The use of immunosuppressive drugs in uveitis.

  1999cites this paper
• The Effect of Immunosuppressive Agents (FK‐506, Rapamycin) on Renal P450 Systems in Rat Models

  1999cites this paper
• マウスのI型(即時型および遅発型)およびIV型(遅延型)皮膚アレルギー反応に対するタクロリムス軟膏の作用

  1998cites this paper
• Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits.

  1998cites this paper
• Update of tacrolimus in pancreas transplantation

  1997cites this paper
• Tacrolimus (FK506)-Associated Renal Pathology.

  1997cites this paper
• Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus.

  1997cites this paper
• Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.

  1997cites this paper
• Use of Tacrolimus (FK506) and Antimetabolites as Immunosuppressants for Xenotransplantation Across Closely Related Rodent Species

  1997cites this paper
• Mode of action of FK-506 on protective immunity to Hymenolepis nana in mice.

  1996cites this paper
• Effect of a single injection of high-dose FK506 on lung transplantation in rats

  1996cites this paper
• Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.

  1996cites this paper
• Tacrolimus (FK506) in Thoracic Organ Transplantation

  1996cites this paper
• LIVER AND INTESTINE TRANSPLANTATION

  1996cites this paper
• Grundlagen immunologischer Vorgänge beim Plattenepithelkarzinom im Kopf-Hals-Bereich — Diagnostik und Ursachen

  1995cites this paper
• Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.

  1995cites this paper
• Phase II FK 506 multicenter concentration control study: one-year follow-up.

  1995cites this paper
• Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.

  1994cites this paper
• Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.

  1994cites this paper
• Characterization of a monoclonal antibody recognizing an epitope designated as canine leukocyte-associated antigen.

  1994cites this paper
• Use of immunosuppressive agents in ocular diseases

  1994cites this paper
• Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A

  1994cites this paper
• The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance.

  1994cites this paper
• DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLs IN VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506

  1993cites this paper
• New immunosuppressive drugs: Mechanisms of action and early clinical experience

  1993cites this paper
• FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.

  1993cites this paper
• Effects of rapamycin on renal microsomal P-450 systems in the rat.

  1993cites this paper
• Structural and functional changes of exocrine pancreas induced by FK506 in rats.

  1993cites this paper
• Inhibition of PHA induced mononuclear cell proliferation by FK506 in combination with cyclosporine, methylprednisolone, 6-mercaptopurine and mycophenolic acid.

  1993cites this paper
• Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

  1993cites this paper
• Japanese study of FK 506 on kidney transplantation: results of late phase II study.

  1993cites this paper
• Enhanced liver regeneration in rats treated with 15-deoxyspergualin alone and in combination with FK 506

  1993cites this paper
• Blockade of interleukin-2 production from cloned T cells by cyclosporine and FK 506 assessed by proliferation assays in vitro.

  1992cites this paper
• A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450.

  1992cites this paper
• Effects of FK506 on Exocrine Pancreas in Rats

  1992cites this paper
• Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study

  1992cites this paper
• The effect of short-term FK 506 therapy on pancreas transplantation using the cuff technique in rats.

  1992cites this paper
• Immunosuppressive effects of FK-506 in canine lung allotransplantation.

  1992cites this paper
• Acute Cellular Rejection Following Liver Transplantation: Clinical Pathologic Features and Effect on Outcome

  1992cites this paper
• The effect of FK506 treatment on pancreaticoduodenal allotransplantation in the primate.

  1992cites this paper
• FK506‐INDUCED IMPAIRMENT OF GLUCOSE METABOLISM IN THE PRIMATE—STUDIES IN PANCREATIC TRANSPLANT RECIPIENTS AND IN NONTRANSPLANTED ANIMALS

  1992cites this paper
• Prospects for synergistic immunosuppressive drug therapy in the coming decade.

  1992cites this paper
• Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study.

  1992cites this paper
• Comparison of cyclosporine and FK506 effects on glutathione levels in rat cochlea, brain, liver and kidney.

  1992cites this paper
• Pathological and immunohistochemical examination in the rat treated with FK 506.

  1991cites this paper
• THE IMMUNOSUPPRESSIVE ANTAGONISM OF LOW DOSES OF FK506 AND CYCLOSPORINE

  1991cites this paper
• The effect of short-term FK 506 therapy on pancreas transplantation in rats.

  1991cites this paper
• Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.

  1991cites this paper
• Canine total orthotopic small bowel transplantation under FK 506.

  1991cites this paper
• New horizons in immunosuppression.

  1991cites this paper
• A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450.

  1991cites this paper
• Effect of donor pretreatment with FK 506 upon small intestine allotransplantation in rats.

  1991cites this paper
• TRANSPLANTATION AND CLINICAL IMMUNOLOGY VOLUME XXII

  1991cites this paper
• Early experience with FK 506 in liver transplantation

  1991cites this paper
• Chapter 22. Mechanism-Based Immunosuppressants

  1991cites this paper
• Inhibition by FK506 of established lesions of collagen‐induced arthritis in rats

  1990cites this paper
• Combined effect of low-dose FK 506 and cyclosporine A on skin graft survival.

  1990cites this paper
• Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity.

  1990cites this paper
• A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.

  1990cites this paper
• The effect of FK 506 on small intestine allotransplantation in the rat.

  1990cites this paper
• Pathologic observations in human allograft recipients treated with FK 506.

  1990cites this paper
• Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506.

  1990cites this paper
• Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical.

  1990cites this paper
• Comparative efficacy of immunosuppressive drugs in xenografting.

  1990cites this paper
• Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey.

  1990cites this paper
• Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.

  1990cites this paper
• Kidney transplantation under FK 506.

  1990cites this paper
• Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice.

  1990cites this paper
• Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.

  1990cites this paper
• FK-506: Profile of an important new immunosuppressant

  1990cites this paper
• SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506: I. PROLONGED CARDIAC AND LIVER SURVIVAL IN RATS FOLLOWING SHORT‐COURSE THERAPY

  1990cites this paper
• The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease.

  1990cites this paper
• Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

  1990cites this paper
• Liver transplantation: a 31-year perspective. Part II.

  1990cites this paper
• Interspecies comparison of the immunosuppressive efficacy and safety of FK 506.

  1990cites this paper
• Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.

  1989cites this paper
• Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report.

  1989cites this paper
• Immunosuppressive Agents (II)

  1989cites this paper
• Toxicity of FK-506 in Human Fetal Pancreas

  1989cites this paper
• Inhibitory effects of FK506 in combination with CsA on human lymphocyte alloproliferative responses

  1989cites this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cites this paper
• Effects of FK-506 on collagen arthritis in mice.

  1989cites this paper
• Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs.

  1989cites this paper
• Prolonged limb allograft survival with short-term treatment with FK-506 in rats.

  1989cites this paper
• Developments in Immunosuppression The Secret to the Success of Organ Transplantation

  1989cites this paper
• Renal transplantation in baboons under FK 506.

  1989cites this paper
• Renal transplantation in baboons under FK 506.

  1989cites this paper
• FK-506--how much potential?

  1989cites this paper
• Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog.

  1989cites this paper
• In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.

  1988cites this paper
• New approaches in the use of cyclosporine: with particular reference to the liver.

  1988cites this paper